BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pido-Lopez J, Tanudjojo B, Farag S, Bondulich MK, Andre R, Tabrizi SJ, Bates GP. Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment. Sci Rep 2019;9:7202. [PMID: 31076648 DOI: 10.1038/s41598-019-43627-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Scheiblich H, Trombly M, Ramirez A, Heneka MT. Neuroimmune Connections in Aging and Neurodegenerative Diseases. Trends in Immunology 2020;41:300-12. [DOI: 10.1016/j.it.2020.02.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
2 Welcome MO. Blood brain barrier inflammation and potential therapeutic role of phytochemicals. PharmaNutrition 2020;11:100177. [DOI: 10.1016/j.phanu.2020.100177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
3 Jamwal S, Elsworth JD, Rahi V, Kumar P. Gene therapy and immunotherapy as promising strategies to combat Huntington's disease-associated neurodegeneration: emphasis on recent updates and future perspectives. Expert Rev Neurother 2020;20:1123-41. [PMID: 32720531 DOI: 10.1080/14737175.2020.1801424] [Reference Citation Analysis]
4 Fatoba O, Ohtake Y, Itokazu T, Yamashita T. Immunotherapies in Huntington's disease and α-Synucleinopathies. Front Immunol 2020;11:337. [PMID: 32161599 DOI: 10.3389/fimmu.2020.00337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Bondulich MK, Fan Y, Song Y, Giorgini F, Bates GP. Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease. Sci Rep 2021;11:5484. [PMID: 33750843 DOI: 10.1038/s41598-021-84858-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Berthelet J, Wimmer VC, Whitfield HJ, Serrano A, Boudier T, Mangiola S, Merdas M, El-Saafin F, Baloyan D, Wilcox J, Wilcox S, Parslow AC, Papenfuss AT, Yeo B, Ernst M, Pal B, Anderson RL, Davis MJ, Rogers KL, Hollande F, Merino D. The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile. Sci Adv 2021;7:eabf4408. [PMID: 34233875 DOI: 10.1126/sciadv.abf4408] [Reference Citation Analysis]
7 Joshi T, Kumar V, Kaznacheyeva EV, Jana NR. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease. Mol Neurobiol 2021;58:3992-4006. [PMID: 33904021 DOI: 10.1007/s12035-021-02397-8] [Reference Citation Analysis]